Sign in
4

Changes in Ownership

CytomX Therapeutics, Inc. Filed Acc 0001140361-17-040976

President and CEO sold 14,342 shares at $19.86 ($284,832)

  • President and CEO acquired 14,342 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

McCarthy Sean A. · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2017-11-01 Exercise or conversion : show line 1 in the form +14,342 $0.95 $13,553 18,587 D
2017-11-01 Sale : show line 2 in the form −14,342 $19.86 $284,832 4,245 D
Open-market sales · 14,342 sh · avg $19.86 · $284,832

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2017-11-01 Exercise or conversion : show line 3 in the form Stock Option (right to buy) −14,342 119,293 D
Loading xslF345X03/doc1.xml…